Filter
561
Text search:
M.tuberculosis
Featured
Recommendations
61
New Publications
106
Language
Document type
No document type
398
Guidelines
70
Studies & Reports
41
Manuals
26
Strategic & Response Plan
11
Training Material
9
Situation Updates
4
Fact sheets
2
Countries / Regions
Western and Central Europe
43
Eastern Europe
25
India
23
Germany
14
Peru
10
Latin America and the Carribbean
10
Nepal
9
Argentina
9
Colombia
9
Ethiopia
8
Tanzania
8
Paraguay
7
Russia
7
Indonesia
6
South Africa
6
Mozambique
6
Ukraine
6
El Salvador
6
Uganda
5
Kenya
5
Cambodia
5
Bangladesh
5
Chile
5
Global
5
Zambia
4
Myanmar / Burma
4
Nigeria
3
Ghana
3
Malawi
3
Namibia
3
Asia
3
Tajikistan
3
Senegal
2
Philippines
2
Benin
2
Brazil
2
Ecuador
2
Bolivia
2
Uruguay
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
USA
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Gambia
1
Eswatini/ Swaziland
1
Switzerland
1
Botswana
1
Lesotho
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
171
Clinical Guidelines
67
Pharmacy & Technologies
10
Public Health
9
Women & Child Health
6
Capacity Building
5
Key Resources
3
Toolboxes
TB
377
HIV
35
AMR
16
NTDs
14
Polio
13
Ebola
12
Refugee
10
Rapid Response
7
Caregiver
5
COVID-19
3
Pharmacy
3
Natural Hazards
2
Mental Health
2
Zika
1
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
Accessed December 2017
10–21 March 2014
Public Health Action PHA 2017; 7(2): 110–115
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu
...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused in name, it offers integration-oriented assessment,
...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)
...
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
Draft for consultation
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
